HSP90AB1 and head and neck squamous cell carcinoma: HNSCC cancer type was chosen as conventionally HNSCC patients are subjected to HT to improve the efficacy of chemo-radiotherapy (CRT), thereby making them a suitable model to evaluate the prognostic potential of HSP90 for predicting the response to HT.